However, oxygen supplementation alone may be insufficient to fully correct persistent, localized hypoxia in severely damaged lung areas post-ARDS, sustaining HIF-1α-driven hypoxic signaling and complicating the distinction between hypoxic and inflammatory contributions to severe COVID-19 pathology [51]. This evidence concerns the gene HIF1A and acute respiratory distress syndrome.